Roberta Santos Azevedo

8PUBLICATIONS
42CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 16, 2026
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

|Jul 13, 2026
Preclinical and clinical efficacy of the HDAC6 inhibitor ricolinostat in combination with BCR pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia.

|May 27, 2026
Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|Dec 03, 2025
Impact of TP53 mutations and their variant allele frequency in adults with newly diagnosed acute lymphoblastic leukemia.

Roberta S Azevedo, Elias Jabbour, Hagop M Kantarjian

|Oct 31, 2025
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia.

Roberta S Azevedo, Julie Braish, Georgina Gener-Ricos

|Oct 10, 2025
CD123 expression and its correlation with mutation profile in acute myeloid leukaemia.

Roberta S Azevedo, Sa A Wang, David M Swanson

Pageof 2

Frequent Collaborators

5 joint publications

Nicholas J Short

4 joint publications

Koji Sasaki

3 joint publications

Omer Karrar

3 joint publications

Hagop Kantarjian